ENANTA PHARMACEUTICALS, INC Maintenance Costs (Deprecated 2018-01-31)
ENANTA PHARMACEUTICALS, INC (ENTA) reported Maintenance Costs (Deprecated 2018-01-31) of $105.00 thousand for the 9-month period ending 2016-06-30, per its 10-Q filed 2016-08-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:MaintenanceCosts · last filed 2016-08-09
- ENANTA PHARMACEUTICALS, INC maintenance costs (deprecated 2018-01-31) for the quarter ending 2016-06-30 was $0.00.
- ENANTA PHARMACEUTICALS, INC maintenance costs (deprecated 2018-01-31) for the quarter ending 2016-03-31 was $0.00.
- ENANTA PHARMACEUTICALS, INC maintenance costs (deprecated 2018-01-31) for the quarter ending 2015-12-31 was $105.00K, a 0.00% change year-over-year.
- ENANTA PHARMACEUTICALS, INC maintenance costs (deprecated 2018-01-31) for the quarter ending 2015-09-30 was $0.00.
- ENANTA PHARMACEUTICALS, INC maintenance costs (deprecated 2018-01-31) for fiscal 2015 was $105.00K.
- ENANTA PHARMACEUTICALS, INC maintenance costs (deprecated 2018-01-31) for fiscal 2013 was $105.00K, a 0.00% change from fiscal 2012.
- ENANTA PHARMACEUTICALS, INC maintenance costs (deprecated 2018-01-31) for fiscal 2012 was $105.00K.
| Period end | Maintenance Costs (Deprecated 2018-01-31) 3 month | Maintenance Costs (Deprecated 2018-01-31) 6 month | Maintenance Costs (Deprecated 2018-01-31) 9 month | Maintenance Costs (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2016-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-09 | $0.00 derived: sum of 2 quarters · filed 2016-08-09 | $105.00K 10-Q · filed 2016-08-09 | $105.00K derived: sum of 4 quarters · filed 2016-08-09 |
| 2016-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-10 | $105.00K 10-Q · filed 2016-05-10 | $105.00K derived: sum of 3 quarters · filed 2016-05-10 | $105.00K derived: sum of 4 quarters · filed 2016-05-10 |
| 2015-12-31 | $105.00K 10-Q · filed 2016-02-09 | $105.00K derived: sum of 2 quarters · filed 2016-02-09 | $105.00K derived: sum of 3 quarters · filed 2016-02-09 | $105.00K derived: sum of 4 quarters · filed 2016-02-09 |
| 2015-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-11 | $0.00 derived: sum of 2 quarters · filed 2015-12-11 | $0.00 derived: sum of 3 quarters · filed 2015-12-11 | $105.00K 10-K · filed 2015-12-11 |
| 2015-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-10 | $0.00 derived: sum of 2 quarters · filed 2015-08-10 | $105.00K 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-08 | $105.00K 10-Q · filed 2015-05-08 | ||
| 2014-12-31 | $105.00K 10-Q · filed 2015-02-06 | |||
| 2014-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-12 | $0.00 derived: sum of 2 quarters · filed 2014-08-12 | $105.00K 10-Q · filed 2014-08-12 | $105.00K derived: sum of 4 quarters · filed 2014-08-12 |
| 2014-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-12 | $105.00K 10-Q · filed 2014-05-12 | $105.00K derived: sum of 3 quarters · filed 2014-05-12 | $105.00K derived: sum of 4 quarters · filed 2014-05-12 |
| 2013-12-31 | $105.00K 10-Q · filed 2014-02-13 | $105.00K derived: sum of 2 quarters · filed 2014-02-13 | $105.00K derived: sum of 3 quarters · filed 2014-02-13 | |
| 2013-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-18 | $0.00 derived: sum of 2 quarters · filed 2013-12-18 | $105.00K 10-K · filed 2013-12-18 | |
| 2013-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-12 | $105.00K 10-Q · filed 2013-08-12 | ||
| 2013-03-31 | $105.00K 10-Q · filed 2013-05-15 | |||
| 2012-09-30 | $105.00K 10-K · filed 2014-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |